Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab-Reference-Cited by-同舟云学术

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab

Published:2015-01-08 Issue:5 Volume:94 Page:813-823
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Berinstein N. L.,Bhella S.,Pennell N. M.,Cheung M. C.,Imrie K. R.,Spaner D. E.,Milliken V.,Zhang L.,Hewitt K.,Boudreau A.,Reis M. D.,Chesney A.,Good D.,Ghorab Z.,Hicks L. K.,Piliotis E.,Buckstein R.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-014-2288-5.pdf

Reference38 articles.

1. Sabloff M, Atkins HL, Bence-Bruckler I, Bredeson C, Fergusson D, Genest P, Hopkins H, Hutton B, McDiarmid S, Huebsch LB (2007) A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma. Biol Blood Marrow Transplant 13(8):956–964. doi: 10.1016/j.bbmt.2007.04.009

2. Ganguly S, Divine CL, Deauna-Limayo D, Bodensteiner DC, Cook JD, Lewis JN, Skikne BS (2005) Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response. Ann Hematol 84(8):526–531. doi: 10.1007/s00277-005-1058-9

3. Schouten HC, Kvaloy S, Sydes M, Qian W, Fayers PM (2000) The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin’s lymphoma (NHL). Ann Oncol 11(Suppl 1):91–94

4. Schouten HC, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnsen HE, Doorduijn JK, Sydes MR, Kvalheim G (2003) High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma: results from the randomized European CUP trial. J Clin Oncol 21(21):3918–3927. doi: 10.1200/JCO.2003.10.023

5. Rohatiner AZ, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J, Gribben JG, Mauch PM, Lister TA, Freedman AS (2007) Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J Clin Oncol 25(18):2554–2559. doi: 10.1200/JCO.2006.09.8327

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term follow‐up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma;British Journal of Haematology;2023-01-10

2. Radionuclide Therapy in Lymphoproliferative Diseases;Radionuclide Therapy;2022

3. Long‐term outcome in patients with follicular lymphoma following high‐dose therapy and autologous stem cell transplantation;European Journal of Haematology;2021-08-03

4. Cellular Therapy in Follicular Lymphoma;Hematology/Oncology Clinics of North America;2020-08

5. The role of stem cell transplantation in follicular lymphoma;Best Practice & Research Clinical Haematology;2018-03